Rayonier Advanced Materials vs Sylvamo
RYAM and SLVM side by side, both in paper and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How RYAM and SLVM compare
Sylvamo is the larger company, worth 4.1 times as much as Rayonier Advanced Materials ($1.5B against $371M).
Sylvamo grew revenue faster over the last twelve months (12.4% versus 1.9% for Rayonier Advanced Materials).
Sylvamo keeps more of each dollar of sales as profit, with a net margin of −4.9% compared with −24.4% at Rayonier Advanced Materials.
Sylvamo pays a dividend yielding 4.7%; Rayonier Advanced Materials does not pay one.
Sylvamo scores higher on the StockData Score (8 against 5 for Rayonier Advanced Materials), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | RYAM | SLVM |
|---|---|---|
| Size and price | ||
| Market cap | $371M | $1.5B |
| Share price | $5.48 | $38.57 |
| Change, 1 year | −9.1% | −17.8% |
| Change, 5 years | −7.6% | 21.7% |
| Beta (5Y) | 1.19 | 0.63 |
| Employees | 2,325 | 6,500 |
| StockData Score | ||
| Total score | 5 | 8 (better) |
| Valuation score | 3 (better) | 2 |
| Growth score | 1 | 1 |
| Performance score | 0 | 0 |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/S | 0.2× (better) | 0.4× |
| P/B | – | 2.1× |
| EV/EBITDA | – | 8.0× |
| FCF yield | – | −3.4% |
| Fair value | $13.29 | $59.76 |
| Margin of safety | 58.8% (better) | 35.5% |
| Growth | ||
| Revenue growth (TTM) | 1.9% | 12.4% (better) |
| Revenue growth, 5Y average | 1.8% | 7.0% (better) |
| Net income growth (TTM) | – | −200% |
| EPS growth (TTM) | – | −204% |
| EPS growth, 5Y average | – | −3.4% |
| Profitability | ||
| Gross margin | 4.5% | 17.8% (better) |
| Operating margin | −17.2% | 2.8% (better) |
| Net margin | −24.4% | −4.9% (better) |
| FCF margin | – | −1.4% |
| Return on equity | −241% | −21.0% (better) |
| Return on invested capital | −23.5% | 4.8% (better) |
| Financial health | ||
| Debt / equity | – | 1.22 |
| Net debt / EBITDA | – | 2.77 |
| Interest coverage | −2.6× | 1.7× (better) |
| Current ratio | 1.28 | 1.29 (better) |
| Altman Z-score | 0.28 | 2.96 (better) |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 4.7% |
| Years of dividend growth | – | 3 |
| Buyback yield | – | 0.00% |
| Shareholder yield | 0.00% | 4.7% (better) |
| Ownership | ||
| Held by institutions | 79.8% | 99.7% |
| Held by insiders | 10.0% | 17.6% |
| Insider net buying, 12 months | −$17.6K (better) | −$658K |
| Short interest, % of float | 7.4% | 7.9% |
Go deeper
- RYAM stock overview
- RYAM income statement
- RYAM valuation and score
- SLVM stock overview
- SLVM income statement
- SLVM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.